Revista nº 812

Efectividad terapias osteonecrosis de los maxilares | González Muñoz M, et al. Actual Med. 2021; 106(812): 66- 77 76 ment of chronic suppurative osteomyelitis: report of 7 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107(2):e1-7. DOI: 10.1016/j.tripleo.2008.09.021 28. Williamson RA. Surgical management of bisphos- phonate induced osteonecrosis of the jaws. Int J Oral Maxillofac Surg. 2010;39(3):251-5. DOI: 10.1016/j. ijom.2009.11.014 29. Atalay B, Yalcin S, Emes Y, Aktas I, Aybar B, Issever H, Mandel NM, Cetin O, Oncu B. Bisphosphonate-related os- teonecrosis: laser-assisted surgical treatment or conven- tional surgery? Lasers Med Sci. 2011;26(6):815-23. DOI: 10.1007/s10103-011-0974-2 30. Hoefert S, Yuan A, Munz A, Grimm M, Elayouti A, Reinert S. Clinical course and therapeutic outcomes of opera- tively and non-operatively managed patients with deno- sumab-related osteonecrosis of the jaw (DRONJ). J Cra- niomaxillofac Surg. 2017;45(4):570-578. DOI: 10.1016/j. jcms.2017.01.013. 31. Kim HY, Lee SJ, Kim SM, Myoung H, Hwang SJ, Choi JY, et al. Extensive Surgical Procedures Result in Better Treat- ment Outcomes for Bisphosphonate-Related Osteone- crosis of the Jaw in Patients With Osteoporosis. J Oral Maxillofac Surg. 2017;75(7):1404-1413. DOI: 10.1016/j. joms.2016.12.014 32. Elad S, Yarom N, Hamed W, Ayalon S, Yahalom R, Regev E. Osteomylelitis and necrosis of the jaw in patients treated with bisphosphonates: a comparative study focused on multiple myeloma. Clin Lab Haematol. 2006;28(6):393-8. DOI: 10.1111/j.1365-2257.2006.00841.x 33. Eckert AW, Maurer P, Meyer L, Kriwalsky MS, Rohrberg R, Schneider D, et al. Bisphosphonate-related jaw necrosis: severe complication in maxillofacial surgery. Cancer Treat Rev. 2007;33(1):58-63. DOI: 10.1016/j.ctrv.2006.09.003 34. Carlson ER, Basile JD. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg. 2009;67(5 Suppl):85-95. DOI: 10.1016/j.joms.2009.01.006 35. Markose G, Mackenzie FR, Currie WJ, Hislop WS. Bisphos- phonate osteonecrosis: a protocol for surgical manage- ment. Br J Oral Maxillofac Surg. 2009;47(4):294-7. DOI: 10.1016/j.bjoms.2009.01.007 36. Stockmann P, Hinkmann FM, Lell MM, Fenner M, Vairakta- ris E, Neukam FW, et al. Panoramic radiograph, computed tomography or magnetic resonance imaging. Which ima- ging technique should be preferred in bisphosphonate-as- sociated osteonecrosis of the jaw? A prospective clinical study. Clin Oral Investig. 2010;14(3):311-7. DOI: 10.1007/ s00784-009-0293-1 37. Hoefert S, Eufinger H. Relevance of a prolonged preopera- tive antibiotic regime in the treatment of bisphosphona- te-related osteonecrosis of the jaw. J Oral Maxillofac Surg. 2011;69(2):362-80. DOI: 10.1016/j.joms.2010.06.200 38. Lemound J, Eckardt A, Kokemüller H, von See C, Voss PJ, Tavassol F, et al. Bisphosphonate-associated os- teonecrosis of the mandible: reliable soft tissue re- construction using a local myofascial flap. Clin Oral Investig. 2012;16(4):1143-52. DOI: 10.1007/s00784- 011-0596-x 39. Wilde F, Heufelder M, Winter K, Hendricks J, Frerich B, Schramm A, et al. The role of surgical therapy in the ma- nagement of intravenous bisphosphonates-related osteo- necrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;111(2):153-63. DOI: 10.1016/j.tri- pleo.2010.04.015 40. Coviello V, Peluso F, Dehkhargani SZ, Verdugo F, Raffaelli L, Manicone PF, et al. Platelet-rich plasma improves wound healing in multiple mieloma bisphosphonate-associated osteonecrosis of the jaw patients. J Biol Regul Homeost Agents. 2012;26(1):151-5. 41. Schubert M, Klatte I, Linek W, Müller B, Döring K, Eckelt U, et al. The saxon bisphosphonate register - therapy and prevention of bisphosphonate-related osteonecrosis of the jaws. Oral Oncol. 2012;48(4):349-54. DOI: 10.1016/j. oraloncology.2011.11.004 42. Voss PJ, Joshi Oshero J, Kovalova-Müller A, Veigel Me- rino EA, Sauerbier S, Al-Jamali J, et al. Surgical treat- ment of bisphosphonate-associated osteonecrosis of the jaw: technical report and follow up of 21 patients. J Craniomaxillofac Surg. 2012;40(8):719-25. DOI: 10.1016/j. jcms.2012.01.005 43. Lopes RN, Rabelo GD, Rocha AC, Carvalho PA, Alves FA. Surgical Therapy for Bisphosphonate-Related Osteone- crosis of the Jaw: Six-Year Experience of a Single Insti- tution. J Oral Maxillofac Surg. 2015;73(7):1288-95. DOI: 10.1016/j.joms.2015.01.008 44. Rugani P, Acham S, Kirnbauer B, Truschnegg A, Oberma- yer-Pietsch B, Jakse N. Stage-related treatment concept of medication-related osteonecrosis of the jaw-a case se- ries. Clin Oral Investig. 2015;19(6):1329-38. DOI: 10.1007/ s00784-014-1384-1 45. Bodem JP, Schaal C, Kargus S, Saure D, Mertens C, Engel M, et al. Surgical management of bisphosphonate-related osteonecrosis of the jaw stages II and III. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;121(4):367-72. DOI: 10.1016/j.oooo.2015.10.033 46. Giudice A, Barone S, Giudice C, Bennardo F, Fortuna- to L. Can platelet-rich fibrin improve healing after sur- gical treatment of medication-related osteonecrosis of the jaw? A pilot study. Oral Surg Oral Med Oral Pa- thol Oral Radiol. 2018;126(5):390-403. DOI: 10.1016/j. oooo.2018.06.007 47. Aljohani S, Troeltzsch M, Hafner S, Kaeppler G, Mast G, Otto S. Surgical treatment of medication-related osteonecrosis of the upper jaw: Case series. Oral Dis. 2019;25(2):497- 507. DOI: 10.1111/odi.12992